Develops long-lasting shots for eczema and asthma.
New: first time
Melqart bought Apogee Therapeutics for the first time between April and June: 117,249 shares, worth about $16 million. That’s already $1 of every $100 they have in stocks.
Mar 31
None
Jun 30
117,249
The numbers
Shares they own
117,249
Value on Jun 30, 2026
$15,562,460
about $16 million
Share of their money
1.5%
$1 of every $100 · 20th of 40
Price per share on Jun 30
$132.73
Kind
Shares
Also owned by
No other fund we follow
More about Apogee Therapeutics ›
The value uses the price on Jun 30, 2026. The fund may have paid a different price.